Visakhapatnam Trivitron Healthcare, a global manufacturer of medical devices, on Friday, announced the inauguration of its Centre of Excellence (CoE) with state-of-the-art R&D and Manufacturing facilities at AMTZ Campus here. The Centre in Metabolomics, Genomics, Newborn Screening, and Molecular Diagnostics, was inaugurated by Prof. Ajay Kumar Sood, Principal Scientific Advisor to the Government of India, and Prof. (Dr) Balram Bhargava, Former Director General, Indian Council of Medical Research in the presence of Dr. GSK Velu, Chairman & Managing Director, Trivitron Healthcare, the Healthcare company said in a release here.
Speaking on the occasion, Dr. Velu said “Trivitron is committed to providing futuristic applications by encompassing advanced R&D, which will be coupled with strong manufacturing capabilities under the supervision of leading scientists and industry experts in this center. This CoE will implement research and innovation in the field of Metabolomics, Genomics, Newborn Screening, and Molecular Diagnostics and bring out cost-effective and affordable medical technology products and services. With 15 certified manufacturing facilities in India, the USA, Finland, Turkey, and China, Trivitron spearheads innovation in the field of InVitro Diagnostics, Medical Imaging, and Critical Care Solutions, Dr. Velu said. By harnessing the enormous power of genomic research and Trivitron’s expertise in advanced diagnostics, this Centre of Excellence will focus on creating unparalleled medical discoveries to transform healthcare delivery. The new center is equipped with state-of-art infrastructure to support the entire product & process development lifecycle at the respective domain-specific labs to achieve optimal scaleup to industrial production, he added.
